ADAR1 Capital Management, LLC
274 holdingsFiling period: 2026-06-30Current AUM: $2.14Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA | 1.85M | $246.4M | $197.2M | 9.19% | +411.1K | 2026-06-30 |
| 2 | PTGX | PROTAGONIST THERAPEUTICS INC | 960.9K | $117.8M | $137.8M | 6.42% | -33,256 | 2026-06-30 |
| 3 | SPY | STATE STR SPDR S&P 500 ETF T | 154.1K | $115.1M | $116.7M | 5.44% | +78.1K | 2026-06-30 |
| 4 | — | ROIVANT SCIENCES LTD | 3.16M | $111.7M | $111.7M | 5.21% | -128,898 | 2026-06-30 |
| 5 | IMVT | IMMUNOVANT INC | 2.33M | $89.8M | $85.4M | 3.98% | -348,294 | 2026-06-30 |
| 6 | ZLAB | ZAI LAB LTD | 3.37M | $64.0M | $83.6M | 3.90% | +1.94M | 2026-06-30 |
| 7 | AGIO | AGIOS PHARMACEUTICALS INC | 1.29M | $47.8M | $42.3M | 1.97% | +1.15M | 2026-06-30 |
| 8 | CRNX | CRINETICS PHARMACEUTICALS IN | 1.22M | $45.7M | $45.7M | 2.13% | +82.7K | 2026-06-30 |
| 9 | BOXX | EA SERIES TRUST | 337.1K | $39.5M | $39.8M | 1.86% | -- | 2026-06-30 |
| 10 | CYTK | CYTOKINETICS INC | 457.9K | $39.0M | $31.7M | 1.48% | -174,649 | 2026-06-30 |
| 11 | SEPN | SEPTERNA INC | 940.7K | $31.5M | $36.6M | 1.70% | -149,071 | 2026-06-30 |
| 12 | AVR | ANTERIS TECHNOLOGIES GLOBAL | 3.15M | $31.0M | $26.2M | 1.22% | -644,036 | 2026-06-30 |
| 13 | EDIT | EDITAS MEDICINE INC | 8.89M | $28.8M | $23.4M | 1.09% | -- | 2026-06-30 |
| 14 | DNLI | DENALI THERAPEUTICS INC | 1.03M | $26.5M | $21.0M | 0.98% | -842,375 | 2026-06-30 |
| 15 | SYRE | SPYRE THERAPEUTICS INC | 284.0K | $25.2M | $25.8M | 1.20% | -54,341 | 2026-06-30 |
| 16 | VIR | VIR BIOTECHNOLOGY INC | 2.46M | $25.0M | $25.6M | 1.20% | -288,037 | 2026-06-30 |
| 17 | PRAX | PRAXIS PRECISION MEDICINES I | 74.3K | $24.9M | $23.2M | 1.08% | +72.8K | 2026-06-30 |
| 18 | INSM | INSMED INC | 228.5K | $24.4M | $27.4M | 1.28% | +193.1K | 2026-06-30 |
| 19 | CLDX | CELLDEX THERAPEUTICS INC NEW | 619.5K | $23.1M | $23.9M | 1.11% | +191.7K | 2026-06-30 |
| 20 | VKTX | VIKING THERAPEUTICS INC | 574.0K | $22.4M | $17.2M | 0.80% | +346.3K | 2026-06-30 |
| 21 | TSHA | TAYSHA GENE THERAPIES INC | 3.04M | $20.7M | $15.4M | 0.72% | +61.0K | 2026-06-30 |
| 22 | MNPR | MONOPAR THERAPEUTICS INC | 217.6K | $20.1M | $22.7M | 1.06% | -46,683 | 2026-06-30 |
| 23 | OVID | OVID THERAPEUTICS INC | 7.42M | $20.0M | $20.1M | 0.94% | +2.87M | 2026-06-30 |
| 24 | ELVN | ENLIVEN THERAPEUTICS INC | 387.7K | $19.7M | $20.7M | 0.96% | +58.2K | 2026-06-30 |
| 25 | ENTA | ENANTA PHARMACEUTICALS INC | 1.34M | $19.6M | $16.5M | 0.77% | +1.29M | 2026-06-30 |
← Scroll →
Page 1 of 11